There was much criticism of those at the helm of the Imugene ship around the decision to acquire AZERCel and the way in which it was funded.
Some of that criticism was very personal and down right abusive.
These results demand that heart felt humble apologies be now tendered but silence will reign and further attacks claiming this will mean another capital raise have already commenced.
The reality is that every announced great result like todays will have a consequence. That consequence is that the trial will continue which is what every real investor in this company wants to happen.
No real investor wants the trials to produce poor or no results because then the trials will not progress and their investment becomes worthless.
Today investors in Imugene have received fantastic early data and in consequence the inherent value of their investment has increased.
Great data equals a great investment.
Great data equals the potential to bring to market life saving cancer treatments.
It is just that simple.
My opinion only DYOR
Fact Finder
There was much criticism of those at the helm of the Imugene...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.7¢ | 4.5¢ | $906.2K | 19.67M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9543864 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 1266571 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |